Alkermes Unveils Investigational Product Designed for Initiation Onto ARISTADA® for Treatment of Schizophrenia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. ANET
3. NKE
4. BE
5. PANW
6. CL
7. SNDK
8. TAP
9. DELL
10. ROIV

Go back to Alkermes Unveils Investigational Product Designed for Initiation Onto ARISTADA® for Treatment of Schizophrenia
ALKERMES (NASDAQ: ALKS) Delayed: 46.10 --0 (-0%)
Previous Close $46.10    52 Week High $80.71 
Open $46.10    52 Week Low $27.14 
Day High $46.10    P/E 354.62 
Day Low $46.10    EPS $0.13 
Volume 41